List view / Grid view
20 June 2018 | By Shimadzu
Redefines Lipidomics and Glycomics Research with Shimadzu's LCMS-9030 Q-TOF Mass Spectrometer...
20 June 2018 | By European Pharmaceutical Review
Researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
20 June 2018 | By Thermo Fisher Scientific
New, easy-to-use analytical detection system extracts meaningful data quickly from acquisition to analysis...
20 June 2018 | By European Pharmaceutical Review
NIH research confirms effective treatments for opioid use disorder are underutilised...
19 June 2018 | By European Pharmaceutical Review
The FDA has approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence...
19 June 2018 | By European Pharmaceutical Review
Aleglitazar improves portal hypertension in rats with cirrhosis by suppressing inflammation, vasoconstriction, and angiogenesis...
19 June 2018 | By Shimadzu
Shimadzu, one of the world's fastest growing mass spectrometry companies, announces the launch of the quadrupole time-of-flight (Q-TOF) LCMS-9030 system...
18 June 2018 | By Waters
New state-of-the-art facility will support continued growth and innovation...
18 June 2018 | By Shimadzu
Shimadzu Scientific Instruments (SSI) announces the release of AuraSolutionTM, SampleStationTM and QC Reporter software packages for the MALDI-8020 linear benchtop system. MALDI-TOF mass spectrometry software packages, which facilitate automated analysis...
18 June 2018 | By European Pharmaceutical Review
An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed...
18 June 2018 | By Thermo Fisher Scientific
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled advances in its leading mass spectrometry portfolio that make these powerful technologies more accessible to scientists across life sciences and applied markets...
18 June 2018 | By European Pharmaceutical Review
Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open...
16 June 2018 | By Waters
Creating access to the power and potential of mass spectrometry for more laboratories...
15 June 2018 | By Shimadzu
Shimadzu is celebrating 30 years as a leader in the development of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). This technology has become ubiquitous in analytical and clinical laboratories because of its versatility, ease of use, low operating costs and unique capabilities...
15 June 2018 | By European Pharmaceutical Review
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest.
Send this to a friend
Follow: